Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
University of Chicago
University of California, San Diego
Tianjin Medical University Cancer Institute and Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gustave Roussy, Cancer Campus, Grand Paris
Dana-Farber Cancer Institute
Shandong Cancer Hospital and Institute
Tata Memorial Centre
University College, London
Women's Cancer Care Associates, LLC
Xi'an Jiaotong University
Columbia University
University Medical Center Groningen
EMD Serono
Loyola University
Obstetrics & Gynecology Hospital of Fudan University
First Affiliated Hospital of Guangxi Medical University
Leiden University Medical Center
University Hospital, Toulouse
Peking Union Medical College Hospital
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Ruijin Hospital
Centre Francois Baclesse, Luxembourg
AIDS Malignancy Consortium
Instituto do Cancer do Estado de São Paulo
Peking Union Medical College Hospital
Washington University School of Medicine
GOG Foundation
Tianjin Medical University Cancer Institute and Hospital
Radiation Therapy Oncology Group
Montefiore Medical Center
Abramson Cancer Center at Penn Medicine
Zhejiang Cancer Hospital
Sun Yat-sen University
Montefiore Medical Center
Sichuan University
Mayo Clinic
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota